Evidence map›Paper›PMID 37156885›Full record

ReviewNature immunology2023

CD4

Marco Künzli, David Masopust

Open access · bronzeAbstract readReview
In one paragraph

Review in Nature immunology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 227 papers.

0numbers the graph read from it
0cells of the map it votes in
227citing papers in PubMed
47.3field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

227 citing papers in PubMed, 288 citations in OpenAlex.

  1. Trial
  2. Trial
  3. Trial
  4. Article
  5. Article
  6. T Cell Thoughts.Immunological reviews · 2026
    Review
  7. Review
  8. Article
  9. Article
  10. Article
  11. Update on environmental determinants of allergic diseases.The Journal of allergy and clinical immunology · 2026
    Review
  12. Review
  13. Article
  14. Review
  15. Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article

167 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 2 institutions in 1 country.

Marco KünzliCenter for Immunology, Department of Microbiology and Immunology, University of Minnesota, Minneapolis, MN, USA.ORCID http://orcid.org/0000-0001-7699-779X
David MasopustCenter for Immunology, Department of Microbiology and Immunology, University of Minnesota, Minneapolis, MN, USA. masopust@umn.edu.ORCID http://orcid.org/0000-0002-9440-3884
University of Minnesota · USUniversity of Minnesota Medical Center · US

Funding

Mucosal T Cell Memory to PathogensR01AI084913 · NIAID · UNIVERSITY OF MINNESOTA · PI MASOPUST, DAVID · 2010 to 2023
$5.8M
Resident Memory T CellsR01AI146032 · NIAID · UNIVERSITY OF MINNESOTA · PI DAVID MASOPUST · 2020 to 2026
$3.8M
Repurposing TRM for tumor immunotherapyR01CA238439 · NCI · UNIVERSITY OF MINNESOTA · PI MASOPUST, DAVID · 2020 to 2024
$2.5M
New mouse model to better predict human immunity to influenza vaccination and infectionR01AI150600 · NIAID · UNIVERSITY OF MINNESOTA · PI LANGLOIS, RYAN, MASOPUST, DAVID · 2021 to 2024
$2.5M
NCI NIH HHS R01 CA238439NIAID NIH HHS R01 AI084913NIAID NIH HHS R01 AI146032NIAID NIH HHS R01 AI150600
6 · The paper itself

Abstract

Specialized subpopulations of CD4

Indexed as

CD4-Positive T-LymphocytesMemory T CellsHumansImmunologic Memory

Identifiers

PMID37156885
PMCPMC10343737
OpenAlexW4375859102

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.